Skip to main content

New funding pushing BioCryst’s flu treatment NDA to finish line

A once-thought-to-be-doomed flu treatment is officially back in play, to the delight of local executives...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.